Vivos (RDGL) Liabilities and Shareholders Equity (2010 - 2025)
Vivos recorded quarterly Liabilities and Shareholders Equity of $1.9 million in Q4 2025, down 18.63% quarter-over-quarter from $2.3 million in Q3 2025, and down 16.38% year-over-year from $2.2 million in Q4 2024.
Vivos' Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $1.9 million for Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity fell 16.38% year-over-year to $1.9 million; the TTM figure through Dec 2025 stood at $10.2 million (up 54.46% YoY), while the FY2025 annual figure was $1.9 million, down 16.38% from the prior year.
- Liabilities and Shareholders Equity came in at $1.9 million for Q4 2025 at Vivos, down from $2.3 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.3 million in Q1 2025 to a low of $1.1 million in Q2 2022.
- A 5-year average of $1.9 million and a median of $1.8 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity soared 3429.68% in 2021 and slumped 50.37% in 2022, its largest moves.
- Vivos' Liabilities and Shareholders Equity stood at $1.6 million in 2021, then gained by 6.64% to $1.7 million in 2022, then dropped by 7.61% to $1.6 million in 2023, then jumped by 38.71% to $2.2 million in 2024, then decreased by 16.38% to $1.9 million in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $1.9 million, $2.3 million, and $2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Vivos | - | - | -3,105.00 | 1.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 2.78 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.74 Mn |
| Sep 30, 2022 | 2.05 Mn |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 1.63 Mn |
| Sep 30, 2021 | 2.04 Mn |
| Jun 30, 2021 | 2.23 Mn |
| Mar 31, 2021 | 2.52 Mn |
| Dec 31, 2020 | 937,539.00 |
| Sep 30, 2020 | 57,903.00 |
| Jun 30, 2020 | 299,559.00 |
| Dec 31, 2019 | 43,873.00 |
| Sep 30, 2019 | 197,058.00 |
| Jun 30, 2019 | 48,287.00 |
| Mar 31, 2019 | 57,319.00 |
| Dec 31, 2018 | 16,486.00 |
| Sep 30, 2018 | 11,731.00 |
| Jun 30, 2018 | 8,161.00 |
| Mar 31, 2018 | 685.00 |
| Dec 31, 2017 | 15,697.00 |
| Sep 30, 2017 | 29,546.00 |
| Jun 30, 2017 | 376,941.00 |
| Mar 31, 2017 | 25,077.00 |
| Dec 31, 2016 | 41,996.00 |
| Sep 30, 2016 | 77,274.00 |
| Jun 30, 2016 | 77,226.00 |
| Mar 31, 2016 | 317,020.00 |
| Dec 31, 2015 | 254,264.00 |
| Sep 30, 2015 | 83,433.00 |
| Jun 30, 2015 | 103,357.00 |
| Mar 31, 2015 | 79,586.00 |
| Dec 31, 2014 | 90,523.00 |
| Sep 30, 2014 | 154,534.00 |
| Jun 30, 2014 | 309,665.00 |
| Mar 31, 2014 | 305,423.00 |
| Dec 31, 2013 | 202,277.00 |
| Sep 30, 2013 | 521,736.00 |
| Jun 30, 2013 | 461,896.00 |
| Mar 31, 2013 | 759,271.00 |
| Dec 31, 2012 | 1.17 Mn |
| Sep 30, 2012 | 819,320.00 |
| Jun 30, 2012 | 886,762.00 |
| Mar 31, 2012 | 969,233.00 |
| Dec 31, 2011 | 1.12 Mn |
| Sep 30, 2011 | 1.22 Mn |
| Jun 30, 2011 | 1.47 Mn |
| Dec 31, 2010 | 2.64 Mn |